Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: GlobeNewswire
SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced select unaudited preliminary results for the fourth quarter and full year ended December 31, 2025, and?provided?full year 2026 financial guidance. These preliminary results will be included in a presentation that will be made available through a live webcast in the investor relations section of the Myriad Genetics website at?investor.myriad.com on Wednesday, January 14,?2026?at 5:15 pm PT (8:15 pm ET) in connection with the company’s presentation at the 44th Annual J.P. Morgan Healthcare Conference. Select Preliminary Fourth Quarter and Full Year 2025 Financial Results? The company expects the following:? Fourth quarter of 2025 total revenues to be between $207 million and $209 million.Full year 2025 total revenues to be between $822 million to $824 million. The company plans to release its actual financial resul
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics Q4 and 2025 revenue ranges include consensus [Seeking Alpha]Seeking Alpha
- What Analysts Think Is Shaping The Story For Myriad Genetics (MYGN) Now [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Looking at the Narrative for Myriad Genetics After Price Target Revisions and Growth Concerns [Yahoo! Finance]Yahoo! Finance
MYGN
Earnings
- 11/3/25 - Beat
MYGN
Sec Filings
- 1/12/26 - Form 8-K
- 1/2/26 - Form 4
- 12/29/25 - Form 4
- MYGN's page on the SEC website